Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Robert Nelsen

Investment Partner , Angel

Overview

Gender
male
Investor Type
Investment Partner,Angel
Investor Stage
Seed

Robert Nelsen is a co-founder and a Managing Director of ARCH Venture Partners. He joined ARCH at its founding and played a significant role in the early sourcing, financing and development of more than 100 companies, including nineteen which have reached valuations exceeding $1 billion. His seed and early-stage investments include Illumina (ILMN); Alnylam Pharmaceuticals (ALNY); Juno Therapeutics (JUNO); Unity Biotechnology (UBX); Sienna Biopharmaceuticals (SNNA); Vir Biotechnology, Agios Pharmaceuticals (AGIO); Sage Therapeutics (SAGE); GRAIL, Ikaria; Kythera Biopharmaceuticals (KYTH), Receptos (RCPT); Aviron (AVIR); Denali Therapeutics (DNLI); Rubius Therapeutics, KSQ Therapeutics, Beam Therapeutics, NetBot; Bluebird Bio (BLUE); R2 Technology; XenoPort (XNPT); Caliper Life Sciences (CALP); Trubion Pharmaceuticals (TRBN); Adolor (ADLR); deCODE Genetics; Array BioPharma (ARRY); Editas (EDIT), IDUN Pharmaceuticals; Classmates.com; Hua Medicine; Fate Therapeutics (FATE); WuxiNextCODE; and Everyday Learning Corporation.

Mr. Nelsen is a director of Vir Bio, GRAIL, Sienna Biopharmaceuticals, Beam Therapeutics, Unity Biotechnology, Denali Therapeutics, Arivale, Syros Pharmaceuticals, and serves as Chairman of Hua Medicine, among others. He previously served as a Trustee of the Fred Hutchinson Cancer Research Institute, the Institute for Systems Biology, and was a director of the National Venture Capital Association. Mr. Nelsen holds an M.B.A. from the University of Chicago and a B.S. from the University of Puget Sound with majors in Economics and Biology.

Personal Investments

Number of Investments
3
Robert Nelsen has made 3 investments. Their most recent investment was on Jun 21, 2019, when Gali Health raised $2M.
Date Company Name Round Money Raised Industry
Mar 9, 2022 Colossal Biosciences Series A $60M Biotechnology Detail
Jul 30, 2021 Neuralink Series C $205M Hardware Detail
Jun 21, 2019 Gali Health Seed $2M Artificial Intelligence Detail

Jobs

Number of Current Jobs
6
Robert Nelsen has 6 current jobs including Board Observer at Synchron , Board Member at Resilience and Co-Founder & Managing Director at ARCH Venture Partners .
Organization Name Title At Company Start Date End Date
Synchron Board Observer Jan 1, 2022 Detail
Resilience Board Member Nov 1, 2020 Detail
ARCH Venture Partners Co-Founder & Managing Director Jan 1, 1986 Detail
Beam Therapeutics Board Member Detail
Prime Medicine Board Member Detail
Neumora Therapeutics Board Member Detail